|
Volumn 49, Issue 4, 2002, Pages 294-298
|
Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine)
a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c |
Author keywords
Adriamycin; Dacarbazine; IFADIC; Ifosfamide; Intestinal permeability; Polydrug chemotherapy
|
Indexed keywords
DACARBAZINE;
DEXAMETHASONE;
DOXORUBICIN;
IFOSFAMIDE;
LACTULOSE;
MANNITOL;
METOCLOPRAMIDE;
ONDANSETRON;
SUCROSE;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DISEASE SEVERITY;
FEMALE;
HUMAN;
INTESTINE ABSORPTION;
INTESTINE MUCOSA PERMEABILITY;
MALE;
NAUSEA;
PRIORITY JOURNAL;
SOFT TISSUE SARCOMA;
TREATMENT OUTCOME;
URINARY EXCRETION;
WORLD HEALTH ORGANIZATION;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DACARBAZINE;
DOXORUBICIN;
FEMALE;
HUMANS;
IFOSFAMIDE;
INTESTINES;
MALE;
MIDDLE AGED;
NAUSEA;
PERMEABILITY;
SARCOMA;
VOMITING;
|
EID: 0036206501
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-001-0414-2 Document Type: Article |
Times cited : (23)
|
References (17)
|